Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1)

 FOREWORD NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):1-2

Diagnosis and therapy of neuroendocrine tumours

Bombardieri E., Virgolini I.


 REVIEWS NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):3-15

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals

Bombardieri E., Coliva A., Maccauro M., Seregni E., Orunesu E., Chiti A., Lucignani G.


 REVIEWS NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):16-23

Imaging of NETs with PET radiopharmaceuticals

Ambrosini V., Tomassetti P., Franchi R., Fanti S.


 REVIEWS NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):24-36

The non tumour uptake of 111In-octreotide creates new clinical indications in benign diseases, but also in oncology

Cascini G. L., Cuccurullo V., Mansi L.


 REVIEWS NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):37-51

Dosimetry for treatment with radiolabelled somatostatin analogues. A review

Cremonesi M., Botta F., Di Dia A., Ferrari M., Bodei L., De Cicco C., Rossi A., Bartolomei M., Mei R., Severi S., Salvatori M., Pedroli G., Paganelli G.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):52-60

Preliminary experience with 68Ga-DOTA-lanreotide positron emission tomography

Traub-Weidinger T., Von Guggenberg E., Dobrozemsky G., Kendler D., Eisterer W., Bale R., Putzer D., Gabriel M., Virgolini I.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):61-7

Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions

Prasad V., Baum R. P.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):68-75

Comparison of 68Ga-DOTA-Tyr3-octreotide and 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients

Putzer D., Gabriel M., Kendler D., Henninger B., Knoflach M., Kroiss A., Vonguggenberg E., Warwitz B., Virgolini I. J.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):76-83

Comparison of positron emission tomography with [18F]FDG and [68Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data

Middendorp M., Selkinski I., Happel C., Kranert W. T., Grünwald F.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):84-91

Treatment with tandem [90Y]DOTA-TATE an [177Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary results

Seregni E., Maccauro M., Coliva A., Castellani M. R., Bajetta E., Aliberti G., Vellani C., Chiesa C., Martinetti A., Bogni A., Bombardieri E.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):92-9

Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients

Gabriel M., Andergassen U., Putzer D., Kroiss A., Waitz D., Von Guggenberg E., Kendler D., Virgolini I. J.


 ORIGINAL ARTICLES NEUROENDOCRINE UPDATE AND METABOLIC THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 February;54(1):100-13

131I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy

Castellani M. R., Seghezzi S., Chiesa C., Aliberti G. L., Maccauro M., Seregni E., Orunesu E., Luksch R., Bombardieri E.


top of page